Showing results (61-70 of 192) with videos related to
Sort By:
Pageof 20
Journal of Clinical Lipidology|August 12, 2014
Hypothyroidism as a risk factor for statin intoleranceCraig D Robison, Tami L Bair, Benjamin D Horne, et al.Journal of Clinical Lipidology|April 29, 2018
Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease-Real-world experience within a large integrated health care system: The IMPRES studyJeffrey L Anderson, Kirk U Knowlton, Heidi T May, et al.BMJ Nutrition, Prevention & Health|January 9, 2023
Association of periodic fasting with lower severity of COVID-19 outcomes in the SARS-CoV-2 prevaccine era: an observational cohort from the INSPIRE registryBenjamin D Horne, Heidi T May, Joseph B Muhlestein, et al.American Heart Journal|January 6, 2005
Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetesMatthew J Kolek, John F Carlquist, Joseph B Muhlestein, et al.Circulation|October 18, 2000
Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery diseaseJ B Muhlestein, B D Horne, J F Carlquist, et al.Journal of the American College of Cardiology|November 25, 2000
Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery diseaseB D Horne, J B Muhlestein, J F Carlquist, et al.Cancer Research|April 20, 2001
Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteinsI B DeRoock, M E Pennington, T C Sroka, et al.Circulation|January 23, 2003
Statin therapy interacts with cytomegalovirus seropositivity and high C-reactive protein in reducing mortality among patients with angiographically significant coronary diseaseBenjamin D Horne, Joseph B Muhlestein, John F Carlquist, et al.The American Journal of Cardiology|November 3, 2004
Early effects of statins in patients with coronary artery disease and high C-reactive proteinJoseph B Muhlestein, Jeffrey L Anderson, Benjamin D Horne, et al.American Heart Journal|August 13, 2011
Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?Jeffrey L Anderson, Ryan C Vanwoerkom, Benjamin D Horne, et al.Pageof 20